SRL
ONCO icon

Scientech Research LLC’s Onconetix ONCO Stock Holding History

Scientech Research LLC’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7
Closed -$2.33K – 785
2025
Q1 		$2.33K Buy
+7
New +$12K ﹤0.01% 539

Other funds holding ONCO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Scientech Research LLC's ONCO Position: Q2 2025 in Review

Scientech Research LLC sold out of Onconetix (ONCO) in Q2 2025, closing a stake of 7 shares — an estimated $2.33K sold.

Scientech Research LLC first reported a position in ONCO in Q1 2025 and held it in 1 quarter. The position peaked at $2.33K in Q1 2025. 5 funds tracked by Wall St. Rank hold ONCO as of Q2 2025.

  • Scientech Research LLC reported no remaining Onconetix position as of Q2 2025 after selling out during the quarter.
  • Scientech Research LLC sold 7 Onconetix shares in Q2 2025, an estimated $2.33K.
  • Scientech Research LLC first reported a position in Onconetix in Q1 2025 and held it in 1 quarter.
  • Scientech Research LLC's Onconetix position peaked at $2.33K in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Onconetix as of Q2 2025.

Based on Scientech Research LLC's 13F filing for Q2 2025, filed 14 Aug 2025.